XML 17 R2.htm IDEA: XBRL DOCUMENT v3.22.2
Unaudited Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Assets    
Cash and cash equivalents $ 707,302 $ 494,711
Restricted cash and restricted cash equivalents [1] 291,631 273,726
Investments in available-for-sale securities (amortized cost of $205,168 and $195,796, respectively) 197,933 194,907
Loans, less allowance for credit losses on loans [1] 8,212,494 6,068,884
Servicing rights 176,964 168,259
Securitization investments 288,717 374,688
Equity method investments 0 19,739
Property, equipment and software 148,744 111,873
Goodwill 1,625,375 898,527
Intangible assets 481,124 284,579
Operating lease right-of-use assets 108,736 115,191
Other assets, less allowance for credit losses of $2,720 and $2,292, respectively 431,866 171,242
Total assets 12,670,886 9,176,326
Deposits:    
Noninterest-bearing deposits 82,801 0
Interest-bearing deposits 2,629,463 0
Total deposits 2,712,264 0
Accounts payable, accruals and other liabilities [1] 542,336 298,164
Operating lease liabilities 131,735 138,794
Debt [1] 3,723,561 3,947,983
Residual interests classified as debt [1] 54,436 93,682
Total liabilities 7,164,332 4,478,623
Commitments, guarantees, concentrations and contingencies (Note 15)
Temporary equity:    
Redeemable preferred stock [2] 320,374 320,374
Equity [Abstract]    
Common stock [3] 92 83
Additional paid-in capital 6,583,405 5,561,831
Accumulated other comprehensive loss (8,011) (1,471)
Accumulated deficit (1,389,306) (1,183,114)
Total permanent equity 5,186,180 4,377,329
Total liabilities, temporary equity and permanent equity $ 12,670,886 $ 9,176,326
[1] Financial statement line items include amounts in consolidated variable interest entities (“VIEs”). See Note 5.(2)As of June 30, 2022 and December 31, 2021, includes loans held for sale measured at fair value of $7,959,382 and $5,952,972, respectively.
[2] Redemption amount is $323,400 as of June 30, 2022 and December 31, 2021.
[3] Includes 100,000,000 non-voting common shares authorized and no non-voting common shares issued and outstanding as of June 30, 2022 and December 31, 2021. See Note 11 for additional information.